David M. Geliebter

David is a co-founder of Martin Pharmaceuticals. A serial entrepreneur, he has over 50 years of experience successfully starting and growing businesses. David founded and ran the Carson Group, global financial information, and advisory company, which was sold to Thomson Corporation in 2000. He was also a founding principal and President of Evolution Capital, a healthcare investment banking firm. David is the Managing Partner of Carrot Capital Healthcare Ventures and founder and board member of Remedy Pharmaceuticals, a CNS-focused pharmaceutical company that sold its lead program, CIRARA (now BIIB093), a repositioned orphan drug, to Biogen for an upfront of $120 million-plus milestones and royalties, and Critical Diagnostics, a diagnostics company focused on cardiac disease. David is a past winner of the Ernst & Young Entrepreneur of the Year Award.